Decline of coronary heart disease mortality in the netherlands from 1978 to 1985: Contribution of medical care and changes over time in presence of major cardiovascular risk factors

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 3, Issue 3, 1996, Pages 271-276

  Bots, Michiel L ^a   Grobbee, Diederick E ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

coronary heart disease; epidemiology; mortality; risk factors; secular trend

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT;

ARTICLE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MEDICAL CARE; MORTALITY; NETHERLANDS; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SMOKING;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANTICOAGULANTS; CORONARY ARTERY BYPASS; CORONARY CARE UNITS; CORONARY DISEASE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SMOKING CESSATION; THROMBOLYTIC THERAPY;

EID: 0029789121     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182679600300302     Document Type: Article

References (44)

1. Thorn TJ: International mortality from heart disease: Rates and trends Int J Epidemiol 1989, 18 (suppl 1):S20-S28.
2. Hoogendoorn D: Is, besides the mortality rate, the incidence of acute myocardial infarction declining? [in Dutch] Ned Tijdschr Geneeskd 1990, 134: 1896-1900.
3. Bots ML Grobbee DE: Cardiovascular diseases in The Netherlands over the past 25 years: Prevalence, incidence, trends of morbidity and mortality Neth J Cardiol 1991, 4: 141-145.
4. Higgins MW Luepeker RV (eds): Trends in Coronary Heart Disease Mortality. The Influence of Medical Care. Oxford: Oxford University Press; 1989.
5. Goldman L Cook F: The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle Ann Intern Med 1984, 101: 825-836.
6. Killip T: Twenty years of coronary bypass surgery N Engl J Med 1988, 319: 366-368.
7. Bal ET Mast EG van den Berg CJM Tjon Joe Gin RM Ernst JMPG Plokker HWM: PTCA, the years after. 7.5 years clinical follow-up after PTCA Neth J Cardiol 1990, 3: 32-36.
8. Yusuf S Peto R Lewis J Collins R Sleight P. Beta blockade during and after myocardial infarction: An overview of the randomized trials Prog Cardiovasc Dis 1985, 27: 335-371.
9. Sixty Plus Reinfarction Study Research Group: A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction Lancet 1980, ii: 989-993.
10. Smith P Arensen H Holme I: The effect of warfarin on mortality and reinfarction after myocardial infarction N Engl J Med 1990, 323: 147-153.
11. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group: Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction Lancet 1994, 343: 499-503.
12. Antiplatelet Trialists’ Collaboration: Collaborative overview of randomised trial of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 1994, 308: 81-106.
13. TIMI Study Group: Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) phase II trial N Engl J Med 1989, 320: 618-627.
14. Simoons ML Vos J Tijssen JGP Vermeer F Verheugt FW Krauss VH etal: Longterm benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands J Am Coll Cardiol 1989, 14: 1609-1615.
15. Dutch Central Bureau of Statistics: Mortality by Cause, Age and Gender, 1969-1990 [in Dutch]. Series A1, 1990.
16. Cole P MacMahon B: Attributable risk percent in case-control studies Br J Prev Soc Med 1971, 25: 242-244.
17. The Netherlands Foundation on Smoking and Health: Annual Report, 1988. The Hague: The Netherlands Foundation on Smoking and Health; 1989.
18. Doll R Peto R: Mortality in relation to smoking: 20 years observation on male British doctors BMJ 1976, 274: 1525-1536.
19. Kannel WB Gordon T: The Framingham Study. An epidemiological investigation of cardiovascular disease. Section 26. Some characteristics related to the incidence of cardiovascular disease and death: 16 year follow-up, 1970. Washington: USA Government Printing Office; 1971.
20. Bots ML Grobbee DE Hofman A: High blood pressure in the elderly Epidemiol Rev 1991, 13: 294-314.
21. Collins R Peto R MacMahon S Herbert P Fiebach NH Eberlein KA etal: Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context Lancet 1990, ii: 827-838.
22. Hoes AW Grobbee DE Valkenburg HA Lubsen J Hofman A: Cardiovascular risk and all-cause mortality. A twelve-year follow-up study in The Netherlands Eur J Epidemiol 1993, 9: 285-292.
23. Witteman JCM Kok FJ van Saase JLCM Hofman A Valkenburg HA: Aortic calcification as a predictor of cardiovascular mortality Lancet 1986, ii: 1120-1122.
24. Continue Moribiditeits Registratie Peilstations Nederland 1985 [in Dutch] Utrecht: Stichting Nederlands Instituut voor Onderzoek van de Eerstelijns-gezondheidszorg (NIVEL); 1985.
25. Fracheboud J: Hartbewaking of thuisblijven?: Een descriptieve studie over thuisbehandeling van patiënten met een hartinfarct in Nederland [in Dutch]. Utrecht: Nederlands Instituut voor Onderzoek van de Eerstelijnsgezond-heidszorg (NIVEL); 1987.
26. Rossouw JE Lewis B Rifkind BM: The value of lowering cholesterol after myocardial infarction N Engl J Med 1990, 323: 1112-1119.
27. Coronary Drug Project Research Group: Natural history of myocardial infarction in the Coronary Drug Project: Long term prognostic importance of lipid levels Am J Cardiol 1978, 42: 489-498.
28. Verschuren WMM Al M Boerma GJM Kromhout D: Trend in serum total cholesterol level in 111 000 young adults in The Netherlands, 1974 to 1986 Am J Epidemiol 1991, 134: 1290-1302.
29. Kromhout D de Lezenne Coulander C Oberman-de Boer GL van Kampen-Donker M Goddijn E Bloemberg BP: Changes in food and nutrient intake in middle-aged men from 1960 to 1985. The Zutphen Study Am J Clin Nutr 1990, 51: 123-129.
30. Hofman A Valkenburg HA: An epidemiological study of cardiovascular risk indicators (EPOZ).II. Prevalence, tracing and treatment of hypertension in an open population [in Dutch] Ned Tijdschr Geneeskd 1980, 124: 189-195.
31. Chiriboga D Yarzebski J Goldberg RJ Gore JM Alpert JS: Temporal trends (1975 through 1990) in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction. A communitywide perspective Circulation 1994, 89: 998-1003.
32. Eccles M Bradshaw C: Use of secondary prophylaxis against myocardial infarction in the north of England BMJ 1991, 302: 91-92.
33. The Netherlands Federation of Thrombosis Centres. Annual Report. The Hague, The Netherlands, 1985.
34. Proudfit WL Kramer JR Goormastic M Loop FD: Survival of non-surgical patients with mild angina or myocardial infarction without angina: A comparison of medical and surgical treatment Br Heart J 1988, 59: 641-647.
35. Proudfit WL Kramer JR Goormastic M Loop FD: Ten-year survival of patients with mild angina or myocardial infarction without angina: A comparison of medical and surgical treatment Am Heart J 1990, 119: 942-947.
36. Califf RM Harrell FE Lee KL Leaverton PE: The evolution of medical and surgical therapy for coronary artery disease JAMA 1989, 261: 2077-2086.
37. Verschuren WMM Boerma GJM Kromhout D: Total and HDL cholesterol in The Netherlands: 1987-1992. Levels and changes over time in relation to age, gender and educational level Int J Epidemiol 1994, 23: 948-956.
38. Rose G: Sick individuals sick populations Int J Epidemiol 1985, 14: 32-38.
39. Beaglehole R: Medical management and the decline in mortality from coronary heart disease BMJ 1986, 292: 33-35.
40. Neutze JM White HD: What contribution has cardiac surgery made to the decline in mortality from coronary heart disease? BMJ 1987, 294: 405-409.
41. Sigfusson N Sigvaldason H Steingridottir L Gudmundsottir II Stefansdottir I Thorsteinsson T etal: Decline in ischaemic heart disease in Iceland and change in risk factor levels BMJ 1991, 302: 1371-1375.
42. Vartiainen E Puska P Pekkanen J Toumilehto J Jousilahti P: Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland BMJ 1994, 309: 23-27.
43. Dobson AJ: Trends in cardiovascular risk factors in Australia, 1966-1986: Evidence from prevalence surveys Community Health Stud 1987, 11: 2-14.
44. Sytkowski PA Kannel WB d'Agostino RB: Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study N Engl J Med 1990, 322: 1635-1641.